More Than You Think: The Hidden Burden of Severe Hypoglycemia in T1D
CME
2
|
MOC
2
|
Nursing
2
More Than You Think: The Hidden Burden of Severe Hypoglycemia in T1D

Severe hypoglycemia happens more often than you think—even in patients with well‑controlled type 1 diabetes. This dynamic, case‑based program uses interactive branching scenarios to mirror real clinical decisions, equipping endocrinologists and the broader endocrine care team to spot hidden risks, improve clinician–patient communication, and close persistent gaps in reporting and detection. Walk away ready to apply advanced treatment and technology strategies while implementing a streamlined practice workflow that includes structured screening, risk stratification, targeted patient education, and timely insulin adjustments.

Register
2
CME

 

Starts

3/31/2026

Expires

3/31/2027

Learning Objectives

Upon program completion, participants should be able to: 

  • Assess patient risk for severe hypoglycemia by incorporating structured screening questions and validated tools during routine clinical visits. 
  • Differentiate between available glucagon formulations to guide appropriate prescribing and improve emergency preparedness. 
  • Evaluate the limitations of CGM and automated insulin delivery (AID) systems in patients with impaired awareness of hypoglycemia to inform individualized treatment adjustments. 
  • Apply guideline-supported, evidence-based practices to revise insulin therapy and glycemic targets following Level 2 and Level 3 hypoglycemic events. 
  • Identify disparities in SH-related care to guide equitable access to diabetes technology, SH treatment options, and diabetes education in at-risk populations. 
Target Audience

The primary target audience for this educational program is US-based endocrinologists and the endocrine care team, including PAs, nurses, and NPs, who diagnose and treat patients with T1D in their clinical practice settings.

Speakers/Faculty

SPEAKERS
FACULTY

Ilias (Elias) Spanakis, MD
Associate Professor of Medicine
University of Maryland School of Medicine

Sarah Nadeem, MD, FACE
Assistant Professor, Baylor College of Medicine
Staff Physician, Michael E. DeBakey VA Medical Center
Section of Endocrinology, Diabetes and Metabolism

Rodolfo J. Galindo, MD, FACE
Associate Professor of Medicine
University of Miami Miller School of Medicine
Director, Comprehensive Diabetes Center
Lennar Medical Center, UMiami Health System
Director, Diabetes Management
Jackson Memorial Health System

Commercial Support

This activity is supported by independent educational grants from Vertex Pharmaceuticals Incorporated and Xeris Pharmaceuticals, Inc.